JP2025507962A5 - - Google Patents
Info
- Publication number
- JP2025507962A5 JP2025507962A5 JP2024552421A JP2024552421A JP2025507962A5 JP 2025507962 A5 JP2025507962 A5 JP 2025507962A5 JP 2024552421 A JP2024552421 A JP 2024552421A JP 2024552421 A JP2024552421 A JP 2024552421A JP 2025507962 A5 JP2025507962 A5 JP 2025507962A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- sulfamoyl
- pharmaceutical composition
- heptanoic acid
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22160079.4 | 2022-03-03 | ||
| EP22160079.4A EP4238557A1 (en) | 2022-03-03 | 2022-03-03 | Gpr120 agonists for the treatment of inflammatory bowel disease |
| PCT/EP2023/055490 WO2023166203A1 (en) | 2022-03-03 | 2023-03-03 | Gpr120 agonists for the treatment of inflammatory bowel disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507962A JP2025507962A (ja) | 2025-03-21 |
| JP2025507962A5 true JP2025507962A5 (cg-RX-API-DMAC10.html) | 2026-02-10 |
Family
ID=80628869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552421A Pending JP2025507962A (ja) | 2022-03-03 | 2023-03-03 | 炎症性腸疾患の治療のためのgpr120アゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250177329A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4238557A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025507962A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119031908A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3248186A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL314689A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023166203A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120919101A (zh) * | 2025-09-26 | 2025-11-11 | 南京农业大学 | Gw9508在制备治疗轮状病毒的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3281937A1 (en) * | 2016-08-09 | 2018-02-14 | Dompé farmaceutici S.p.A. | Sulfonamides as gpr40- and gpr120-agonists |
| CN111317728A (zh) * | 2018-12-14 | 2020-06-23 | 中国科学院大连化学物理研究所 | 天然来源ffa4(gpr120)受体激动剂及其应用 |
-
2022
- 2022-03-03 EP EP22160079.4A patent/EP4238557A1/en not_active Withdrawn
-
2023
- 2023-03-03 EP EP23708797.8A patent/EP4486327A1/en active Pending
- 2023-03-03 WO PCT/EP2023/055490 patent/WO2023166203A1/en not_active Ceased
- 2023-03-03 CN CN202380023191.0A patent/CN119031908A/zh active Pending
- 2023-03-03 US US18/843,373 patent/US20250177329A1/en active Pending
- 2023-03-03 IL IL314689A patent/IL314689A/en unknown
- 2023-03-03 JP JP2024552421A patent/JP2025507962A/ja active Pending
- 2023-03-03 CA CA3248186A patent/CA3248186A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3031577T3 (en) | Treatment of type 2 diabetes with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof | |
| JPH09505829A (ja) | 炎症および炎症関連障害を処置するための1,4,5−トリフェニルピラゾリル化合物 | |
| JPH0948728A (ja) | 解熱鎮痛剤 | |
| JP2006510603A (ja) | R−非ステロイド性抗炎症薬エステル及びそれらの使用 | |
| US20230002336A1 (en) | MrgprX2 Antagonists and Uses Thereof | |
| US20210403434A1 (en) | Metabolically stable 5-hmf derivatives for the treatment of hypoxia | |
| WO2023169557A1 (zh) | 一种次黄碱衍化合物在制备治疗肺纤维化药物中的应用 | |
| KR20100135700A (ko) | 지방성 간 질환의 치료용 의약 조성물 | |
| WO2002045750A1 (en) | Combination drugs | |
| US6455567B1 (en) | Method of treatment | |
| JP4608093B2 (ja) | 組合せ製剤としてのエンドセリン拮抗剤およびβ−受容体ブロッカー | |
| ES2234234T3 (es) | Procedimiento para el tratamiento de la enfermedad pulmonar obstructiva cronica. | |
| FR2550091A1 (fr) | Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne | |
| US11807604B1 (en) | Pharmaceutical compounds, pharmaceutical compositions, and methods of treating asthma and other disorders | |
| KR20090093807A (ko) | 신경보호효과를 가지는 피루베이트 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 | |
| EP2146714A1 (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson | |
| JP2025507962A (ja) | 炎症性腸疾患の治療のためのgpr120アゴニスト | |
| JP4393203B2 (ja) | ビグアニド誘導体及びそれを含有する糖尿病治療剤 | |
| RU2024129167A (ru) | Агонисты gpr120 для лечения воспалительных заболеваний кишечника | |
| JP4145042B2 (ja) | 併用薬 | |
| JP2013014569A (ja) | ジフェニルメチルピペラジン誘導体、及びそれを用いた医薬組成物 | |
| JP2006096664A (ja) | 肝繊維化抑制剤 | |
| JP2004115508A (ja) | 熱傷皮膚組織の機能改善のための医薬 | |
| WO2021191305A1 (en) | Cxcl8 inhibitors for use in the treatment of covid-19 | |
| EP4008325A1 (en) | Cxcl8 inhibitors for use in the treatment of covid-19 |